Hypertension Control and Cardiovascular Risk Profiles in Patients with Established Coronary Artery Disease: A Single-Centre Study
DOI:
https://doi.org/10.12928/admj.v7i1.15077Keywords:
Coronary Artery Disease, Secondary Prevention, hypertension controlAbstract
Coronary artery disease (CAD) remains a leading cause of global morbidity and mortality, driven by interconnected risk factors such as hypertension, diabetes mellitus, smoking, obesity, and dyslipidemia. Effective management of these factors is essential in secondary prevention. This study aimed to compare the level of hypertension control with other cardiometabolic risk factors among CAD patients. Using a cross-sectional design, 40 CAD patients with multiple risk factors at Mitra Medika Amplas Hospital were assessed for hypertension control, smoking status, blood glucose regulation, achievement of ideal body weight, and dyslipidemia management based on clinical measurements and questionnaire data. Data were analyzed using descriptive statistics. Associations between risk factors and their level of control were assessed using the Chi-square test, with Fisher’s exact test applied when expected cell counts were small. Hypertension emerged as the most well-controlled risk factor, whereas blood glucose, body weight, and especially dyslipidemia showed poor levels of control. The study also found that an increasing number of coexisting risk factors correlated with progressively lower control of each individual factor. These findings underscore the need for more comprehensive, structured, and multidisciplinary risk-factor management to improve the effectiveness of secondary prevention in CAD patients.
References
Patriyani REH, Purwanto DF. Faktor dominan risiko terjadinya penyakit jantung koroner (PJK). J Keperawatan Glob. 2016;1(1):23-30.
Kementerian Kesehatan Republik Indonesia. Pedoman Nasional Pelayanan Kedokteran Tata Laksana Penyakit Jantung Koroner. 2020.
Kemenkes RI. Hipertensi penyebab utama penyakit jantung, gagal ginjal, dan stroke. Kementerian Kesehatan Republik Indonesia. 2021. Accessed November 14, 2025. sehatnegeriku.kemkes.go.id
Peltzer K, Pengpid S. The prevalence and social determinants of hypertension among adults in Indonesia: A cross-sectional population-based national survey. Int J Hypertens. Published online 2018:1-9.
Susanti N, Siregar PA, Falefi R. Determinan kejadian hipertensi masyarakat pesisir berdasarkan kondisi sosio-demografi dan konsumsi makan. Determinan kejadian hipertensi masyarakat pesisir berdasarkan kondisi sosio-demografi dan konsumsi makan. 2020;2(1):43-52.
Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/1186/2022 tentang Panduan Praktik Klinis bagi Dokter di Fasilitas Pelayanan Kesehatan Tingkat Pertama. Jakarta: Kementerian Kesehatan RI; 2022.
Laranjo L, Lanas F, Sun MC, et al. World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update. Glob Heart. 2024;19(1). doi:10.5334/gh.1278
Winnige P, Vysoky R, Dosbaba F, Batalik L. Cardiac rehabilitation and its essential role in the secondary prevention of cardiovascular diseases. World J Clin Cases. 2021;9(8):1761-1784. doi:10.12998/wjcc.v9.i8.1761
Rodriguez F, Lee UJ, Barone N, et al. Risk factor control across the spectrum of cardiovascular risk: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Am J Prev Cardiol. 2021;5:100147. doi:10.1016/j.ajpc.2021.100147
Reda A, Ragy H, Saeed K, Alhussaini MA. A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes. Journal of the Egyptian Public Health Association. 2021;96(1):32. doi:10.1186/s42506-021-00096-9
Lee J, Son H, Ryu OH. Management Status of Cardiovascular Disease Risk Factors for Dyslipidemia among Korean Adults. Yonsei Med J. 2017;58(2):326. doi:10.3349/ymj.2017.58.2.326
Nurwinda Sari N, Yuliana D, Agata A, Febriawati H. Faktor karakteristik responden yang berhubungan dengan manajemen pengendalian hipertensi. Jurnal Keperawatan. 2023;15(1):69-76.
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188. doi:10.1093/eurheartj/ehz455
Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;143(21). doi:10.1161/CIR.0000000000000973
Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016;26(6):515–523. doi:10.1016/j.tcm.2016.03.001
Lüscher TF. Prevention: From Lifestyle Changes to Medication. Eur Heart J. 2018;39(25):2333-2336. doi:10.1093/eurheartj/ehy371
Dhungana RR, Khanal MK, Pandey AR. Prevalence and Associated Risk Factors of Hypertension in a Rural Community of Western Nepal: A Cross Sectional Study. Journal of Advances in Internal Medicine. 2018;7(1):11-16.
Emerging Risk Factors Collaboration. Body-mass index and risk of cardiovascular disease. Lancet Diabetes Endocrinol. 2021;9(10):678-689.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ahmad Handayani, Farha Sonia Safar, Muhammad Ary Guhtama
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. Please also carefully read Ahmad Dahlan Medical Journal posting Your Article Policy.
- That it is not under consideration for publication elsewhere.
- That its publication has been approved by all the author(s) and by the responsible authorities - tacitly or explicitly - of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with Ahmad Dahlan Medical Journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
